RD, L., AVS, M., PGM, d. B. E. S., RJ, M., TM, D. S., L, M., . . . OF, d. S. (2021). Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial. JAMA, 325(3), 254. https://doi.org/10.1001/jama.2020.25864
Chicago Style (17th ed.) CitationRD, Lopes, et al. "Effect of Discontinuing Vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial." JAMA 325, no. 3 (2021): 254. https://doi.org/10.1001/jama.2020.25864.
MLA (9th ed.) CitationRD, Lopes, et al. "Effect of Discontinuing Vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19: A Randomized Clinical Trial." JAMA, vol. 325, no. 3, 2021, p. 254, https://doi.org/10.1001/jama.2020.25864.